Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Frontiers in Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
Front Neurol 2020 Jul 01;11(xx)417, B Raffaelli, R Kalantzis, J Mecklenburg, LH Overeem, L Neeb, A Gendolla, U ReuterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.